TABLE 1.
Clinical data of participants at baseline
| Total (N = 50) | without events (n = 38) | with events (n = 12) | p-value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 63 (9.8) | 62 (10.1) | 67 (7.7) | 0.113 |
| Sex (men) | 46 (92.0) | 35 (92.1) | 11 (91.7) | 1.000 |
| Risk factors | ||||
| Smoking | 27 (54.0) | 17 (44.7) | 10 (83.3) | 0.019 |
| Alcohol abuse | 23 (46.0) | 17 (44.7) | 6 (50.0) | 0.750 |
| Diabetes mellitus | 11 (22.0) | 5 (13.2) | 6 (50.0) | 0.014 |
| Hypertension | 31 (62.0) | 25(65.8) | 6 (50.0) | 0.496 |
| Family history | 21 (42.0) | 14 (36.8) | 7 (58.3) | 0.189 |
| Serological indicators | ||||
| Triglyceride level (mmol/L) | 1.51 (1.05–1.70) | 1.51 (1.05–2.04) | 1.50 (1.01–1.65) | 0.547 |
| Cholesterol level (mmol/L) | 3.93 (3.35–4.75) | 3.91 (3.35–4.78) | 4.13 (3.44–4.67) | 0.691 |
| LDL level (mmol/L) | 2.46 (1.87–3.06) | 2.36 (1.74–2.93) | 2.71 (2.22–3.49) | 0.195 |
| HDL level (mmol/L) | 1.12 (0.91–1.24) | 1.12 (0.92–1.25) | 1.11 (0.87–1.24) | 0.586 |
| FBG level (mmol/L) | 5.08 (4.67–5.98) | 4.88 (4.60–5.56) | 5.76 (5.33–6.85) | 0.011 |
| Carotid revascularization | 19 (38.0) | 14 (36.8) | 5 (41.7) | 1.000 |
| Medication adherence | 41 (82.0) | 32 (84.2) | 9 (75.0) | 0.668 |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; FBG, fasting blood-glucose.
Numbers are presented as n (%), mean (SD) or median (IQR).